ConductScience.org, home

Library / Genes

SDC1: syndecan 1

1 protein, 107 patents, 1 drug, 3 trials, 6,216 NIH grants and 17,613 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSDC1HGNC
Namesyndecan 1HGNC
NCBI Gene ID6382NCBI Gene
HGNC IDHGNC:10658HGNC
EnsemblENSG00000115884NCBI Gene
AliasesCD138, SDC, SYND1, syndecanNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P18827Syndecan-13103Ensembl, GeneID, HGNCUniProt

Patents 107

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4716700 A22026-04-0123P18827Espacenet
JP 2026004432 A2026-01-1432P18827Espacenet
JP 2026004568 A2026-01-1466148P18827Espacenet
JP 2026004568 A2026-01-1466149P18827Espacenet
US 12514926 B22026-01-0632P18827Espacenet
EP 4650780 A22025-11-191493P18827Espacenet
JP 2025147176 A2025-10-0611728P18827Espacenet
JP 2025147176 A2025-10-0611729P18827Espacenet
JP 2025133077 A2025-09-106P18827Espacenet
JP 2025529142 A2025-09-043859P18827Espacenet

Drugs 1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
INDATUXIMAB RAVTANSINECHEMBL1743031Syndecan-1 binding agentBINDING AGENTChEMBL

Trials 3

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT01638936INDATUXIMAB RAVTANSINEPHASE1/PHASE2ClinicalTrials.gov
NCT01001442INDATUXIMAB RAVTANSINEPHASE1/PHASE22018-05-08ClinicalTrials.gov
NCT00723359INDATUXIMAB RAVTANSINEPHASE1ClinicalTrials.gov

NIH grants 6216

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant1032,025NIH's project files
P01CA155258Integrative Oncogenomics of Multiple Myeloma992,025NIH's project files
P30CA008748Cancer Center Support Grant962,025NIH's project files
P50CA186781Mayo Clinic Multiple Myeloma SPORE532,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant382,025NIH's project files
I01BX001584Molecular Manipulation to Enhance Anti-Myeloma Response292,025NIH's project files
P30CA014520UW Comprehensive Cancer Center Support292,025NIH's project files
P30CA086862Cancer Center Support Grant292,025NIH's project files
P30CA006973Regional Oncology Research Center252,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award222,025NIH's project files

Papers 17613

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826002PubTator, text miningPubMed
42824828PubTator, text miningPubMed
42821454PubTator, text miningPubMed
42818791PubTator, text miningPubMed
42814322PubTator, text miningPubMed
42798643PubTator, text miningPubMed
42795819PubTator, text miningPubMed
42794683PubTator, text miningPubMed
42785046PubTator, text miningPubMed
42784877PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license